EE200000625A - Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised - Google Patents

Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised

Info

Publication number
EE200000625A
EE200000625A EEP200000625A EEP200000625A EE200000625A EE 200000625 A EE200000625 A EE 200000625A EE P200000625 A EEP200000625 A EE P200000625A EE P200000625 A EEP200000625 A EE P200000625A EE 200000625 A EE200000625 A EE 200000625A
Authority
EE
Estonia
Prior art keywords
acetylcholine
compositions
buffered
stabilizing
product
Prior art date
Application number
EEP200000625A
Other languages
English (en)
Inventor
Tsao Fu-Pao
Edward Minno George
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200000625A publication Critical patent/EE200000625A/et
Publication of EE04515B1 publication Critical patent/EE04515B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polymerisation Methods In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000625A 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised EE04515B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29
PCT/EP1999/002846 WO1999055304A1 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Publications (2)

Publication Number Publication Date
EE200000625A true EE200000625A (et) 2002-02-15
EE04515B1 EE04515B1 (et) 2005-08-15

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000625A EE04515B1 (et) 1998-04-29 1999-04-27 Atsetlkoliinkoostiste stabiliseerimise meetodidja koostised

Country Status (25)

Country Link
US (1) US6261546B1 (et)
EP (1) EP1073413B1 (et)
JP (1) JP2002512945A (et)
KR (1) KR100617429B1 (et)
CN (1) CN1147289C (et)
AT (1) ATE286380T1 (et)
AU (1) AU745124B2 (et)
BR (1) BR9910077A (et)
CA (1) CA2327398C (et)
CZ (1) CZ301969B6 (et)
DE (1) DE69923063T2 (et)
EE (1) EE04515B1 (et)
ES (1) ES2235486T3 (et)
HK (1) HK1034204A1 (et)
HU (1) HU226104B1 (et)
ID (1) ID26032A (et)
IL (1) IL138775A0 (et)
NO (1) NO20005372L (et)
NZ (1) NZ507074A (et)
PL (1) PL194092B1 (et)
PT (1) PT1073413E (et)
RU (1) RU2225199C2 (et)
SI (1) SI1073413T1 (et)
UA (1) UA72209C2 (et)
WO (1) WO1999055304A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2670436A1 (en) 2006-11-30 2008-06-05 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
JP2002512945A (ja) 2002-05-08
ES2235486T3 (es) 2005-07-01
CN1298295A (zh) 2001-06-06
PL343174A1 (en) 2001-07-30
SI1073413T1 (et) 2005-08-31
KR100617429B1 (ko) 2006-08-30
NZ507074A (en) 2004-02-27
CZ20003961A3 (cs) 2001-01-17
PT1073413E (pt) 2005-04-29
CA2327398A1 (en) 1999-11-04
IL138775A0 (en) 2001-10-31
DE69923063D1 (de) 2005-02-10
HU226104B1 (en) 2008-04-28
EP1073413B1 (en) 2005-01-05
HK1034204A1 (en) 2001-10-19
DE69923063T2 (de) 2005-12-22
ID26032A (id) 2000-11-16
BR9910077A (pt) 2000-12-26
HUP0100613A3 (en) 2001-12-28
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
US6261546B1 (en) 2001-07-17
HUP0100613A2 (hu) 2001-08-28
EE04515B1 (et) 2005-08-15
RU2225199C2 (ru) 2004-03-10
PL194092B1 (pl) 2007-04-30
WO1999055304A1 (en) 1999-11-04
NO20005372D0 (no) 2000-10-25
CA2327398C (en) 2008-12-30
UA72209C2 (en) 2005-02-15
CZ301969B6 (cs) 2010-08-18
CN1147289C (zh) 2004-04-28
NO20005372L (no) 2000-10-25
EP1073413A1 (en) 2001-02-07
AU4034099A (en) 1999-11-16
KR20010043121A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
DE69617273D1 (de) Heterocyclisch substituierte cyclopentanderivate.
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
DK1273299T3 (da) Minoxidilinindeholdende praparater
HUP0000564A2 (hu) Olajos szuszpenzió alakú gyógyászati készítmények
YU78202A (sh) Tečne formulacije
WO2002028829A3 (en) Peptide deformylase inhibitors
JO1696B1 (en) Acetamide derivatives
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
GEP20084346B (en) Protein kinase c inhibitors
ES2111272T3 (es) Mezclas herbicidas.
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
EE200000625A (et) Atsetüülkoliinkoostiste stabiliseerimise meetodidja koostised
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DE69626544T2 (de) Arzneistoffe
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
EA200200775A1 (ru) Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
ATE386524T1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110427